A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and Hyperlipidemia
Clinical trial NCT05643508 · COMPLETED
Trial details
- NCT number
- NCT05643508
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-23
- Primary completion
- 2024-09-10
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.